newsfilter
← Latest News
PR Newswire·

Karyopharm to Report First Quarter 2026 Financial Results on May 14, 2026

  • Karyopharm Therapeutics Inc. (Nasdaq: KPTI) will report first quarter 2026 financial results on Thursday, May 14, 2026.
  • Management will host a conference call & audio webcast at 8:00 a.m. ET to discuss results & company updates.
  • Dial-in numbers are (800) 836-8184 (local) or (646) 357-8785 (international), requiring a 10-minute early arrival.
  • The live webcast, slides, & an archived version available two hours post-event will be on the investor website under "Events & Presentations."
  • XPOVIO (selinexor) is a first-in-class oral XPO1 inhibitor approved in the U.S. & over 50 ex-U.S. territories, including the EU, UK (as NEXPOVIO), & China.
  • The company focuses on a pipeline for multiple myeloma, endometrial cancer, & myelofibrosis.